Last reviewed · How we verify
Ibuprofen 200 mg
At a glance
| Generic name | Ibuprofen 200 mg |
|---|---|
| Also known as | Brufen, Advil, Motrin, Nurofen, Immediate Release Tablet |
| Sponsor | University of Colorado, Denver |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions (PHASE1)
- Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery (PHASE4)
- Helping Osteoarthritis Patients to Walk With NSAID (PHASE4)
- Mechanisms of Action of Acetaminophen (NA)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- TENS Unit To Decrease Pain After Laminaria Insertion (NA)
- Meloxicam in Mohs Micrographic Surgery (PHASE4)
- Postoperative Pain Management in Rhinoplasty (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ibuprofen 200 mg CI brief — competitive landscape report
- Ibuprofen 200 mg updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI